Immunogen | IMGN - Прибыль до налогообложения



Прибыль до налогообложения Изменить Дата
AbbVie USD 7.61B 2.04B 2026-06
Agios Pharmaceuticals USD -99.11M 9.94M 2026-03
Amgen USD 2.08B 570M 2026-03
Astellas Pharma JPY 186.51B 138.49B 2026-06
AstraZeneca USD 4.81B 894M 2026-06
Bristol-Myers Squibb USD 4.99B 1.75B 2026-06
Eli Lilly USD 8.85B 583.8M 2026-03
Exelixis USD 262.68M 5.01M 2026-06
Halozyme Therapeutics USD 180.33M 281.18M 2026-03
Heron Therapeutics USD -2.95M 14.54M 2025-12
Intrexon USD -60.48M 27.09M 2024-06
Karyopharm Therapeutics USD -22.39M 17.51M 2026-03
MacroGenics USD -36.77M 21.84M 2026-03
Nektar Therapeutics USD -43.09M 8.39M 2026-03
Novartis USD 3.84B 1.33B 2026-03
Pfizer USD -653M 5.84B 2026-06
Regeneron Pharmaceuticals USD 1.53B 696.6M 2026-06
Roche Holding CHF 11.17B 6.38B 2026-06
Sanofi EUR 2B 3.16B 2026-03